These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30955154)

  • 1. Catheter-related infections in peritoneal dialysis: comparison of a single center results and the literature data.
    Milan Manani S; Virzì GM; Giuliani A; Crepaldi C; Ronco C
    J Nephrol; 2019 Oct; 32(5):837-841. PubMed ID: 30955154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
    Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
    Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.
    Iida H; Kurita N; Fujimoto S; Kamijo Y; Ishibashi Y; Fukuma S; Fukuhara S
    Int Urol Nephrol; 2018 Apr; 50(4):763-769. PubMed ID: 29349637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exit-Site Relocation: A Novel, Straightforward Technique for Exit-Site Infections.
    Kirmizis D; Bowes E; Ansari B; Cairns H
    Perit Dial Int; 2019; 39(4):350-355. PubMed ID: 31123073
    [No Abstract]   [Full Text] [Related]  

  • 10. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.
    Santos C; Pérez-Fontán M; Rodríguez-Carmona A; Calvo-Rodríguez M; López-Muñiz A; López-Calviño B; García-Falcón T
    Perit Dial Int; 2016; 36(1):43-51. PubMed ID: 25292406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
    Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
    Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of exit-site infection in incident peritoneal dialysis patients.
    Lin J; Ye H; Li J; Qiu Y; Wu H; Yi C; Lu S; Chen J; Mao H; Huang F; Yu X; Yang X
    Perit Dial Int; 2020 Mar; 40(2):164-170. PubMed ID: 32072873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.